Literature DB >> 20195565

[HIV-associated neuropathies].

K Hahn1, I W Husstedt.   

Abstract

Human immunodeficiency virus (HIV)-associated polyneuropathy has become the most common neurological complication of HIV infection and is one of the main risk factors for development of a neuropathy worldwide. Therefore HIV should always be considered as an underlying cause in patients with neuropathy. Many types of peripheral neuropathies are seen in HIV infection depending on the stage of infection. The inflammatory demyelinating neuropathies both acute (Guillain-Barré syndrome, GBS) and chronic (chronic inflammatory demyelinating neuropathy, CIDP) occur mainly at the time of seroconversion or early in the course of the disease while syndromes associated with opportunistic infections like CMV (i.e. polyradiculoneuropathy) occur in the late phase of HIV infection and are related to the loss of immune function. Distal symmetrical polyneuropathy (DSP) is the most common neuropathy in HIV-infected patients. We review the clinical manifestations, epidemiology, clinical diagnostics, pathophysiology and management strategies for HIV-associated polyneuropathies.

Entities:  

Mesh:

Year:  2010        PMID: 20195565     DOI: 10.1007/s00115-010-2931-x

Source DB:  PubMed          Journal:  Nervenarzt        ISSN: 0028-2804            Impact factor:   1.214


  58 in total

1.  A sicca syndrome in HIV infection: association with HLA-DR5 and CD8 lymphocytosis.

Authors:  S Itescu; L J Brancato; R Winchester
Journal:  Lancet       Date:  1989-08-26       Impact factor: 79.321

2.  A randomized controlled trial of duloxetine in diabetic peripheral neuropathic pain.

Authors:  J F Wernicke; Y L Pritchett; D N D'Souza; A Waninger; P Tran; S Iyengar; J Raskin
Journal:  Neurology       Date:  2006-10-24       Impact factor: 9.910

3.  Guillain-Barré syndrome associated with human immunodeficiency virus infection in Zimbabwe.

Authors:  C A Thornton; A S Latif; J C Emmanuel
Journal:  Neurology       Date:  1991-06       Impact factor: 9.910

Review 4.  Ganciclovir and foscarnet efficacy in AIDS-related CMV polyradiculopathy.

Authors:  H J Anders; N Weiss; J R Bogner; F D Goebel
Journal:  J Infect       Date:  1998-01       Impact factor: 6.072

Review 5.  [Peripheral nerve diseases and myopathies associated with HIV infection].

Authors: 
Journal:  Nervenarzt       Date:  2000-06       Impact factor: 1.214

6.  Peripheral neuropathy in human immunodeficiency virus-infected patients with the diffuse infiltrative lymphocytosis syndrome.

Authors:  A Moulignier; F J Authier; M Baudrimont; G Pialoux; L Belec; M Polivka; B Clair; F Gray; J Mikol; R K Gherardi
Journal:  Ann Neurol       Date:  1997-04       Impact factor: 10.422

7.  Morphometric analysis of the peripheral neuropathy of AIDS.

Authors:  W G Bradley; P Shapshak; S Delgado; I Nagano; R Stewart; B Rocha
Journal:  Muscle Nerve       Date:  1998-09       Impact factor: 3.217

8.  A randomized trial of amitriptyline and mexiletine for painful neuropathy in HIV infection. AIDS Clinical Trial Group 242 Protocol Team.

Authors:  K Kieburtz; D Simpson; C Yiannoutsos; M B Max; C D Hall; R J Ellis; C M Marra; R McKendall; E Singer; G J Dal Pan; D B Clifford; T Tucker; B Cohen
Journal:  Neurology       Date:  1998-12       Impact factor: 9.910

9.  Differential effects of HIV infected macrophages on dorsal root ganglia neurons and axons.

Authors:  Katrin Hahn; Barry Robinson; Caroline Anderson; Wenxue Li; Carlos A Pardo; Susan Morgello; David Simpson; Avindra Nath
Journal:  Exp Neurol       Date:  2007-07-06       Impact factor: 5.330

10.  Complement dependent cytotoxicity of sensory ganglion neurons mediated by the gp120 glycoprotein of HIV-1.

Authors:  S Apostolski; T McAlarney; A P Hays; N Latov
Journal:  Immunol Invest       Date:  1994-01       Impact factor: 3.657

View more
  4 in total

Review 1.  The HIV-1 transgenic rat model of neuroHIV.

Authors:  Michael Vigorito; Kaitlyn P Connaghan; Sulie L Chang
Journal:  Brain Behav Immun       Date:  2015-02-27       Impact factor: 7.217

2.  Influence of short-term glucocorticoid therapy on regulatory T cells in vivo.

Authors:  Silviu Sbiera; Thomas Dexneit; Sybille D Reichardt; Kai D Michel; Jens van den Brandt; Sebastian Schmull; Luitgard Kraus; Melanie Beyer; Robert Mlynski; Sebastian Wortmann; Bruno Allolio; Holger M Reichardt; Martin Fassnacht
Journal:  PLoS One       Date:  2011-09-02       Impact factor: 3.240

3.  Acute hemiplegia as a rare presentation of infantile Guillain-Barre syndrome.

Authors:  Mahmood D Al-Mendalawi
Journal:  Saudi Med J       Date:  2014-11       Impact factor: 1.484

4.  A comparative study of CIDP in a cohort of HIV-infected and HIV-uninfected patients.

Authors:  Kaminie Moodley; Pierre L A Bill; Vinod Bhagu Patel
Journal:  Neurol Neuroimmunol Neuroinflamm       Date:  2016-12-15
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.